Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jaya Chakravarty & Shyam Sundar. (2019) Current and emerging medications for the treatment of leishmaniasis. Expert Opinion on Pharmacotherapy 20:10, pages 1251-1265.
Read now
Read now
Carolina Bruno de Sousa, João Henrique G. Lago, Jorge Macridachis, Marta Oliveira, Luis Brito, Catarina Vizetto-Duarte, Cláudia Florindo, Sarah Hendrickx, Louis Maes, Thiago Morais, Miriam Uemi, Luís Neto, Lídia Dionísio, Sofia Cortes, Luísa Barreira, Luísa Custódio, Fernando Alberício, Lenea Campino & João Varela. (2019) Report of in vitro antileishmanial properties of Iberian macroalgae. Natural Product Research 33:12, pages 1778-1782.
Read now
Read now
Shyam Sundar, Jaya Chakravarty & Lalit P Meena. (2019) Leishmaniasis: treatment, drug resistance and emerging therapies. Expert Opinion on Orphan Drugs 7:1, pages 1-10.
Read now
Read now
Natascia Bruni, Barbara Stella, Leonardo Giraudo, Carlo Della Pepa, Daniela Gastaldi & Franco Dosio. (2017) Nanostructured delivery systems with improved leishmanicidal activity: a critical review. International Journal of Nanomedicine 12, pages 5289-5311.
Read now
Read now
Rajan Kumar Pandey, Bajarang Vasant Kumbhar, Shubham Srivastava, Ruchi Malik, Shyam Sundar, Ambarish Kunwar & Vijay Kumar Prajapati. (2017) Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 35:1, pages 141-158.
Read now
Read now
Rajan Kumar Pandey, Drista Sharma, Tarun Kumar Bhatt, Shyam Sundar & Vijay Kumar Prajapati. (2015) Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach. Journal of Biomolecular Structure and Dynamics 33:12, pages 2541-2553.
Read now
Read now
Articles from other publishers (35)
Boobalan Gopu, Parampreet Kour, Ramajayan Pandian & Kuljit Singh. (2023) Insights into the drug screening approaches in leishmaniasis. International Immunopharmacology 114, pages 109591.
Crossref
Crossref
André L.S. Santos, Ana Karina C. Lima, Simone S.C. Oliveira, Rosiane F. dos Santos, Michael Devereux, Malachy McCann, Marta H. Branquinha & Patrícia M.L. Dutra. (2022) Decoding the anti-Leishmania braziliensis activity of 1,10-phenanthroline-5,6-dione and its silver- and copper-based complexes: In vitro and in vivo approaches. European Journal of Medicinal Chemistry Reports 6, pages 100093.
Crossref
Crossref
Henry Nettey, Isaac Joe Erskine, Afia Antwi Mensah, Nana Kwame Ofori Gyamera, Charles Kwadwo Obuobi, Doris Kumadoh, Isaac Julius Asiedu-Gyekye & Grace Lovia Allotey-Babington. (2022) Oral amodiaquine microparticles repurposed for the treatment of visceral leishmaniasis. Scientific African 17, pages e01285.
Crossref
Crossref
Laura Dirkx, Sarah Hendrickx, Margot Merlot, Dimitri Bulté, Marick Starick, Jessy Elst, André Bafica, Didier G. Ebo, Louis Maes, Johan Van Weyenbergh & Guy Caljon. (2022) Long-term hematopoietic stem cells as a parasite niche during treatment failure in visceral leishmaniasis. Communications Biology 5:1.
Crossref
Crossref
Gilbert O. Silveira, Helena S. Coelho, Murilo S. Amaral & Sergio Verjovski-Almeida. (2021) Long non-coding RNAs as possible therapeutic targets in protozoa, and in Schistosoma and other helminths. Parasitology Research 121:4, pages 1091-1115.
Crossref
Crossref
Manoj Kumar Singh, Arpita Das, Rudra P Saha, Joydeep Paul & Debkumar Nandi. (2022) Leishmaniasis: Plants as a source of antileishmanial agents. Journal of Experimental Biology and Agricultural Sciences 10:1, pages 227-247.
Crossref
Crossref
Pedro Alves Bezerra Morais, Carla Santana Francisco, Heberth de Paula, Rayssa Ribeiro, Mariana Alves Eloy, Clara Lirian Javarini, Álvaro Cunha Neto & Valdemar Lacerda Júnior. (2021) Semisynthetic Triazoles as an Approach in the Discovery of Novel Lead Compounds. Current Organic Chemistry 25:10, pages 1097-1179.
Crossref
Crossref
Aline N. Silva da Gama & Maria N.C. Soeiro. (2021) Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents. Current Pharmaceutical Design 27:15, pages 1757-1762.
Crossref
Crossref
Diana Caridha, Richard J. Sciotti, Jason Sousa, Brian Vesely, Tesfaye Teshome, Gustave Bonkoungou, Chau Vuong, Susan Leed, Mozna Khraiwesh, Erica Penn, Mara Kreishman-Deitrick, Patricia Lee, Brandon Pybus, John S. Lazo & Elizabeth R. Sharlow. (2021)
Combination of Subtherapeutic Doses of Tretazicar and Liposomal Amphotericin B Suppresses and Cures
Leishmania major
-Induced Cutaneous Lesions in Murine Models
. ACS Infectious Diseases 7:2, pages 506-517.
Crossref
Crossref
Lipika Ray, R. Karthik, Vikas Srivastava, Sheelendra Pratap Singh, A. B. Pant, Neena Goyal & Kailash C. Gupta. (2020) Efficient antileishmanial activity of amphotericin B and piperine entrapped in enteric coated guar gum nanoparticles. Drug Delivery and Translational Research 11:1, pages 118-130.
Crossref
Crossref
Camila S. Freitas, João A. Oliveira-da-Silva, Daniela P. Lage, Rafaella R. Costa, Débora V. C. Mendonça, Vívian T. Martins, Thiago A. R. Reis, Luciana M. R. Antinarelli, Amanda S. Machado, Grasiele S. V. Tavares, Fernanda F. Ramos, Vinicio T. S. Coelho, Rory C. F. Brito, Fernanda Ludolf, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Gabriela S. Ramos, Jennifer Munkert, Flaviano M. Ottoni, Priscilla R. V. Campana, Maria V. Humbert, Elaine S. Coimbra, Fernão C. Braga, Rodrigo M. Pádua & Eduardo A. F. Coelho. (2020) Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Parasitology Research 120:1, pages 321-335.
Crossref
Crossref
Neena Goyal, Manveer Patel & Sanjay Batra. 2021. Drug Discovery and Drug Development. Drug Discovery and Drug Development
123
158
.
Debarati Mukherjee, Md Yousuf, Somaditya Dey, Sondipon Chakraborty, Ankur Chaudhuri, Vinay Kumar, Biswajyoti Sarkar, Supriya Nath, Aabid Hussain, Aritri Dutta, Tanushree Mishra, Biswajit Gopal Roy, Sushma Singh, Sibani Chakraborty, Susanta Adhikari & Chiranjib Pal. (2020)
Targeting the Trypanothione Reductase of Tissue-Residing
Leishmania
in Hosts’ Reticuloendothelial System: A Flexible Water-Soluble Ferrocenylquinoline-Based Preclinical Drug Candidate
. Journal of Medicinal Chemistry 63:24, pages 15621-15638.
Crossref
Crossref
Camila Marques Queiroz, Gevanio Bezerra de Oliveira Filho, José Wanderlan Pontes Espíndola, Amanda Vasconcelos do Nascimento, Amanda Silva dos Santos Aliança, Virginia Maria Barros de Lorena, Ana Paula Sampaio Feitosa, Paula Roberta da Silva, Luiz Carlos Alves, Ana Cristina Lima Leite & Fábio André Brayner. (2020) Thiosemicarbazone and thiazole: in vitro evaluation of leishmanicidal and ultrastructural activity on Leishmania infantum. Medicinal Chemistry Research 29:11, pages 2050-2065.
Crossref
Crossref
Ona Illa, José-Antonio Olivares, Nerea Gaztelumendi, Laura Martínez-Castro, Jimena Ospina, María-Ángeles Abengozar, Giuseppe Sciortino, Jean-Didier Maréchal, Carme Nogués, Míriam Royo, Luis Rivas & Rosa M. Ortuño. (2020) Chiral Cyclobutane-Containing Cell-Penetrating Peptides as Selective Vectors for Anti-Leishmania Drug Delivery Systems. International Journal of Molecular Sciences 21:20, pages 7502.
Crossref
Crossref
Rubem Figueiredo Sadok Menna-Barreto. (2019) Cell death pathways in pathogenic trypanosomatids: lessons of (over)kill. Cell Death & Disease 10:2.
Crossref
Crossref
Vladimir V. Kouznetsov, Carlos M. Meléndez Gómez, José Luis Valencia Peña & Leonor Y. Vargas-Méndez. 2019. Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases. Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases
87
164
.
Erika G. Pinto & Andre G. Tempone. (2018) Activity of the antiarrhythmic drug amiodarone against Leishmania (L.) infantum: an in vitro and in vivo approach. Journal of Venomous Animals and Toxins including Tropical Diseases 24:1.
Crossref
Crossref
Yih Ching Ong, Lukasz Kedzierski & Philip C Andrews. (2018) Do bismuth complexes hold promise as antileishmanial drugs?. Future Medicinal Chemistry 10:14, pages 1721-1733.
Crossref
Crossref
SHYAM SUNDAR & ANUP SINGH. (2017) Chemotherapeutics of visceral leishmaniasis: present and future developments. Parasitology 145:4, pages 481-489.
Crossref
Crossref
Róbson Ricardo Teixeira, Poliana Aparecida Rodrigues Gazolla, Adalberto Manoel da Silva, Maria Paula Gonçalves Borsodi, Bartira Rossi Bergmann, Rafaela Salgado Ferreira, Boniek Gontijo Vaz, Géssica Adriana Vasconcelos & Wallace Pacienza Lima. (2018) Synthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalities. European Journal of Medicinal Chemistry 146, pages 274-286.
Crossref
Crossref
Chen Zhang, Sandra Bourgeade Delmas, Álvaro Fernández Álvarez, Alexis Valentin, Catherine Hemmert & Heinz Gornitzka. (2018) Synthesis, characterization, and antileishmanial activity of neutral N-heterocyclic carbenes gold(I) complexes. European Journal of Medicinal Chemistry 143, pages 1635-1643.
Crossref
Crossref
Vanessa Yardley & Markella Koniordou. 2017. Drug Discovery for Leishmaniasis. Drug Discovery for Leishmaniasis
55
76
.
Andrew M. Thompson, Patrick D. O’Connor, Andrew J. Marshall, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stephanie Braillard, Eric Chatelain, Scott G. Franzblau, Baojie Wan, Yuehong Wang, Zhenkun Ma, Christopher B. Cooper & William A. Denny. (2017)
7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-
b
][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis
. Journal of Medicinal Chemistry 60:10, pages 4212-4233.
Crossref
Crossref
Aya Hefnawy, Maya Berg, Jean-Claude Dujardin & Géraldine De Muylder. (2017) Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs. Trends in Parasitology 33:3, pages 162-174.
Crossref
Crossref
Swati Pund & Amita Joshi. 2017. Nano- and Microscale Drug Delivery Systems. Nano- and Microscale Drug Delivery Systems
439
480
.
M. E. Della Pepa, F. Martora, E. Finamore, M. Vitiello, M. Galdiero & G. Franci. 2017. Nanotechnology Applied To Pharmaceutical Technology. Nanotechnology Applied To Pharmaceutical Technology
307
333
.
Amyra Amat Sain, Azimah Amanah, Zuriati Zahari, Roshan Jahn Mohd Salim, Sharif Mahsufi Mansor & Mohd Ilham Adenan. (2016) (+)-Spectaline, a Piperidine Alkaloid from <i>Senna spectabilis</i> DC. Effective in Reducing the <i>In Vitro</i> Infection of <i>Leishmania major</i>. International Journal of Pharmacology, Phytochemistry and Ethnomedicine 3, pages 1-8.
Crossref
Crossref
Shyam Sundar & Anup Singh. (2016) Recent developments and future prospects in the treatment of visceral leishmaniasis. Therapeutic Advances in Infectious Disease 3:3-4, pages 98-109.
Crossref
Crossref
Helene Djakpa, Aditya Kulkarni, Scheneque Barrows‐Murphy, Greg Miller, Weihong Zhou, Hyejin Cho, Béla Török & Kimberly Stieglitz. (2016) Identifying New Drug Targets for Potent Phospholipase D Inhibitors: Combining Sequence Alignment, Molecular Docking, and Enzyme Activity/Binding Assays. Chemical Biology & Drug Design 87:5, pages 714-729.
Crossref
Crossref
Pankaj K. Singh, Prachi Sah, Jaya Gopal Meher, Sumit Joshi, Vivek K. Pawar, Kavit Raval, Yuvraj Singh, Komal Sharma, Animesh Kumar, Anuradha Dube & Manish K. Chourasia. (2016) Macrophage-targeted chitosan anchored PLGA nanoparticles bearing doxorubicin and amphotericin B against visceral leishmaniasis. RSC Advances 6:75, pages 71705-71718.
Crossref
Crossref
Wagner Pereira, Raphael de Souza Vasconcellos, Christiane Mariotini-Moura, Rodrigo Saar Gomes, Rafaela Firmino, Adalberto da Silva, Abelardo Silva Júnior, Gustavo Bressan, Márcia Almeida, Luís Crocco Afonso, Róbson Teixeira & Juliana Lopes Rangel Fietto. (2015) The Antileishmanial Potential of C-3 Functionalized Isobenzofuranones against Leishmania (Leishmania) Infantum Chagasi. Molecules 20:12, pages 22435-22444.
Crossref
Crossref
Nathanial K. Copeland & Naomi E. Aronson. (2015) Leishmaniasis. Current Opinion in Infectious Diseases 28:5, pages 426-437.
Crossref
Crossref
Xiaohua Zhu, Kurt S. Van Horn, Megan M. Barber, Sihyung Yang, Michael Zhuo Wang, Roman Manetsch & Karl A. Werbovetz. (2015) SAR refinement of antileishmanial N2,N4-disubstituted quinazoline-2,4-diamines. Bioorganic & Medicinal Chemistry 23:16, pages 5182-5189.
Crossref
Crossref
Lucie Paloque, Catherine Hemmert, Alexis Valentin & Heinz Gornitzka. (2015) Synthesis, characterization, and antileishmanial activities of gold(I) complexes involving quinoline functionalized N-heterocyclic carbenes. European Journal of Medicinal Chemistry 94, pages 22-29.
Crossref
Crossref